Detection of drug resistance-associated genes of multidrug-resistant Acinetobacter baumannii

Microbial Drug Resistance

Volumn 14, Issue 2, 2008, Pages 145-150

  Yin, Xiao Lin ^a   Hou, Tian Wen ^b   Xu, Shu Bin ^b   Ma, Cui Qing ^a   Yao, Zhi Yan ^a   Li, Wei ^b   Wei, Lin ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OLIGONUCLEOTIDE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULPERAZON; SULTAMICILLIN; TAZOBACTAM; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DNA SEQUENCE; GENE AMPLIFICATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; BACTERIAL INFECTION; CHINA; CLASSIFICATION; CROSS INFECTION; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHINA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 50149085820     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2008.0799     Document Type: Article

References (20)

1. Afzal-Shah, M., N. Woodfood, and D.M. Livermore. 2001. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45:583-588.
2. Bergogne-Berezin, E., and K.J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
3. Chu, Y.W., M. Afzal-Shah, E.T. Houang, M.I. Palepou, D.J. Lyon, N. Woodford, and D.M. Livermore. 2001. IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob. Agents Chemother. 45:710-714.
4. Corbella, X., A. Montero, M. Pujol, M.A. Dominguez, J. Ayats, M.J. Argerich, F. Garrigosa, J. Ariza, and F. Gudiol. 2000. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J. Clin. Microbiol. 38:4086-4095.
5. Gallego, L., and K.J. Towner. 2001. Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. J. Med. Microbiol. 50:71-77.
6. Go, E.S., C. Urban, J. Bruns, B. Kreiswirth, W. Eisner, N. Mariano, K. Mosinka-Sripas, and J.J. Rahal. 1994. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 344:1329-1332.
7. Gouby, A., M.J. Carles-Nurit, N. Bouziges, G. Bourg, R. Mesnard, and P.J. Bouvet. 1992. Use of pulsed-field gel electrophoresis for investigation of hospital outbreaks of Acinetobacter baumannii. J. Clin. Microbiol. 30:1588-1591.
8. Huang, Z.M., P.H. Mao, Y. Chen, L. Wu, and J. Wu. 2004. Study on molecular epidemiology of SHV type beta-lactamase-encoding genes of multiple-drug-resistant Acinetobacter baumannii. Zhonghua Liu Xing Bing Xue Za Zhi. 25:425-427.
9. Hujer, K.M., N.S. Hamza, A.M. Hujer, F. Perez, M.S. Helfand, C.R. Bethel, J.M. Thomson, V.E. Anderson, M. Barlow, L.B. Rice, F.C. Tenover, and R.A. Bonomo. 2005. Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes. Antimicrob. Agents Chemother. 49:2941-2948.
10. Karlowsky, J.A., D.C. Draghi, M.E. Jones, C. Thornsberry, I.R. Friedland, and D.F. Sahm. 2003. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States. Antimicrob. Agents Chemother. 47:1681-1688.
11. Koljalg, S., P. Naaber, and M. Mikelsaar. 2002. Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility. J. Hosp. Infect. 52:106-113.
12. Maguire, A.J., D.F. Brown, J.J. Gray, and U. Desselberger. 2001. Rapid screening technique for class 1 integrons in Enterobacteriaceae and nonfermenting gram-negative bacteria and its use in molecular epidemiology. Antimicrob. Agents Chemother. 45:1022-1029.
13. Manikal, V.M., D. Landman, G. Saurina, E. Oydna, H. Lal, and J. Quale. 2000. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin. Infect. Dis. 31:101-106.
14. Naas, T., P. Bogaerts, C. Bauraing, Y. Degheldre, Y. Glupczynski, and P. Nordmann. 2006. Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium. J. Antimicrob. Chemother. 58:178-182.
15. Nagano, N., Y. Nagano, C. Cordevant, N. Shibata, and Y. Arakawa. 2004. Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J. Clin. Microbiol. 42:3978-3984.
16. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement Approved Standard M100-S14, pp. 36-38. Wayne, Pennsylvania.
17. Poirel, L., O. Menuteau, N. Agoli, C. Cattoen, and P. Nordmann. 2003. Outbreak of extended-spectrum betalactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J. Clin. Microbiol. 41:3542-3547.
18. Takahashi, A., S. Yomoda, I. Kobayashi, T. Okubo, M. Tsunoda, and S. Iyobe. 2000. Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. J. Clin. Microbiol. 38:526-529.
19. Tenover, F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain tying. J. Clin. Microbiol. 33:2233-239.
20. Vahaboglu, H., F. Coskunkan, O. Tansel, R. Ozturk, N. Sahin, I. Koksal, B. Kocazeybek, M. Tatman-Otkun, H. Leblebicioglu, M.A. Ozinel, H. Akalin, S. Kocagoz, and V. Korten. 2001. Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J. Med. Microbiol. 50:642-645.